REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,923,240 | +44.9% | 31,500 | +26.5% | 0.04% | +37.5% |
| Q2 2023 | $17,891,646 | +39.6% | 24,900 | +59.6% | 0.03% | +39.1% |
| Q1 2023 | $12,818,052 | +407.6% | 15,600 | +345.7% | 0.02% | +360.0% |
| Q4 2022 | $2,525,215 | +1729.9% | 3,500 | +1650.0% | 0.01% | – |
| Q3 2022 | $138,000 | -84.4% | 200 | -86.7% | 0.00% | -100.0% |
| Q2 2022 | $887,000 | -53.0% | 1,500 | -44.4% | 0.00% | 0.0% |
| Q1 2022 | $1,886,000 | -6.7% | 2,700 | -15.6% | 0.00% | 0.0% |
| Q4 2021 | $2,021,000 | -18.5% | 3,200 | -22.0% | 0.00% | -50.0% |
| Q3 2021 | $2,481,000 | +122.1% | 4,100 | +105.0% | 0.00% | +100.0% |
| Q2 2021 | $1,117,000 | +68.7% | 2,000 | +42.9% | 0.00% | 0.0% |
| Q1 2021 | $662,000 | -94.4% | 1,400 | -92.6% | 0.00% | -92.9% |
| Q2 2020 | $11,849,000 | +405.5% | 19,000 | +295.8% | 0.01% | +366.7% |
| Q1 2020 | $2,344,000 | -52.3% | 4,800 | -63.4% | 0.00% | -25.0% |
| Q4 2019 | $4,919,000 | +65.7% | 13,100 | +22.4% | 0.00% | +33.3% |
| Q3 2019 | $2,968,000 | +50.5% | 10,700 | +69.8% | 0.00% | +50.0% |
| Q2 2019 | $1,972,000 | -5.8% | 6,300 | +23.5% | 0.00% | 0.0% |
| Q1 2019 | $2,094,000 | -87.0% | 5,100 | -88.1% | 0.00% | -88.9% |
| Q4 2018 | $16,061,000 | -23.0% | 43,000 | -16.7% | 0.02% | -5.3% |
| Q3 2018 | $20,848,000 | +1.1% | 51,600 | -13.7% | 0.02% | -5.0% |
| Q2 2018 | $20,630,000 | +6.0% | 59,800 | +5.8% | 0.02% | +5.3% |
| Q1 2018 | $19,456,000 | -76.7% | 56,500 | -74.6% | 0.02% | -71.2% |
| Q4 2017 | $83,614,000 | -9.7% | 222,400 | +7.4% | 0.07% | -17.5% |
| Q3 2017 | $92,599,000 | +22.0% | 207,100 | +34.0% | 0.08% | +9.6% |
| Q2 2017 | $75,930,000 | +37.0% | 154,600 | +8.1% | 0.07% | +35.2% |
| Q1 2017 | $55,414,000 | -26.5% | 143,000 | -30.3% | 0.05% | -20.6% |
| Q4 2016 | $75,364,000 | +93.3% | 205,300 | +111.6% | 0.07% | +78.9% |
| Q3 2016 | $38,996,000 | +15.5% | 97,000 | +0.3% | 0.04% | +5.6% |
| Q2 2016 | $33,771,000 | +172.4% | 96,700 | +181.1% | 0.04% | +157.1% |
| Q1 2016 | $12,399,000 | -29.1% | 34,400 | +6.8% | 0.01% | -30.0% |
| Q4 2015 | $17,480,000 | +96.8% | 32,200 | +68.6% | 0.02% | +81.8% |
| Q3 2015 | $8,884,000 | +35.0% | 19,100 | +48.1% | 0.01% | +57.1% |
| Q2 2015 | $6,581,000 | +40.2% | 12,900 | +24.0% | 0.01% | +40.0% |
| Q1 2015 | $4,695,000 | – | 10,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 72,600 | $42,916,000 | 0.05% |
| JANE STREET GROUP, LLC | 74,600 | $44,098,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 11,800 | $6,975,000 | 0.01% |
| HRT FINANCIAL LP | 700 | $413,000 | 0.01% |
| Allianz Asset Management GmbH | 1,500 | $887,000 | 0.00% |
| JPMORGAN CHASE & CO | 3,100 | $1,833,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |